Name | Benzenepropanamide, N-[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)methyl]-2,6-difluoro-β-methyl- |
---|
Description | AGPS-IN-1 (Compound 2i) is an effective AGPS binder. AGPS-IN-1 reduces ether lipids levels and cell migration rate. AGPS-IN-1 inhibits epithelial-mesenchymal transition (EMT) in prostate PC-3 and breast MDA-MB-231 cancer cells[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C18H17F2N3O2 |
---|---|
Molecular Weight | 345.34 |